IFIH1 and interstitial lung disease: The demographics, clinical manifestations, laboratory test results at diagnosis, pulmonary function test results, and BALF analyses of the 333 enrolled patients with IIM-ILD having either anti-MDA5 or anti-ARS antibodies are summarized in Table 1.